Moderna Inc. (NASDAQ: MRNA) is a biotechnology company that develops therapeutics and vaccines. The products are based on messenger RNA targetting the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases.
MRNA Moderna Inc NASDAQ
125.61 USD -1.02% -1.29
OPEN 126.59
PREV CLOSE 126.90
DAY RANGE 127.09 - 125.30
VOLUME 2.5M
AVG. VOLUME 3.2M
52 WEEK RANGE 217.25 - 115.03
Buy MRNA stocks now with Interactive Brokers – the most advanced investment platform
Valuations metrics
Market capitalization 47.9B
Enterprise value 40.6B
Trailing pe 10.875324
Forward pe -31.014814
Peg ratio -31.014814
Price to sales ttm 3.179737
Price to book mrq 2.5571027
Enterprise to revenue 2.693
Enterprise to ebitda 7.839
Financials
Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.31768
Operating margin 0.32054
Return on assets ttm 0.11663
Return on equity ttm 0.26624
Income statement
Revenue ttm 15.1B
Revenue per share ttm 38.613
Quarterly revenue growth -0.693
Gross profit ttm 10.6B
Ebitda 9.8B
Net income to common ttm 4.8B
Diluted eps ttm 11.55
Quarterly earnings growth yoy -0.978
Balance sheet
Total cash mrq 8.9B
Total cash per share mrq 23.407
Total debt mrq 1.1B
Total debt to equity mrq 5.874
Current ratio mrq 3.464
Book value per share mrq 49.122
Cash flow
Operating cash flow ttm 1B
Levered free cash flow ttm 541.9M
Stock statistics
Shares outstanding 381.2M
Float shares 344M
Avg 10 volume 3.2M
Avg 30 volume 3.3M
Shares short 18.2M
Short ratio 5.02
Short percent of shares outstanding 0.0636
Percent held by insiders 0.09607001
Percent held by institutions 0.68328005
Stock price summary
Fifty two week low 115.03
Fifty two week high 217.25
Fifty two week change -6.711
Beta 1.692124
Day 50 ma 138.2758
Day 200 ma 153.49052
